Understanding common side effects 1 The most common adverse reactions, reported in 5% of patients treated with RYBELSUS are: nausea diarrhea vomiting abdominal pain decreased appetite constipation nausea abdominal pain diarrhea decreased appetite vomiting constipation In the pool of placebo-controlled trials, the majority of reports of nausea, vomiting, and/or diarrhea occurred during dose escalation
Study procedure (Koide et al., 2025) GLP-1RA therapy significantly reduced blood glucose levels, body weight, and body fat percentage Results showed that after 12 months of treatment, GLP-1RA therapy significantly reduced participants blood glucose levels (as measured by glycated hemoglobin), body weight, and body fat percentage
During Your Remaining Appointments GLP-1 injections only need to be given once per week as a subcutaneous injection
How GLP-1 Supportive Foods Contribute to Your Wellness Goals Focusing on GLP-1 supportive foods can help you experience steadier energy